Fig S4 shows that 100% of CLL and B-cell lymphoma samples co-express Lck and Lyn. Additionally, we observed that Lck levels vary depending on how samples are prepared. For example, CLL6 showed lower levels of Lck protein when cell pellets were lysed in Ripa buffer (Fig. 4A), yet Lck was readily detected from a second blood-draw when cell pellets were lysed in concentrated SDS sample buffer (Fig. 4B). In the same sample, we found that both Y394 and Y505 sites were phosphorylated, suggesting that Src kinases are constitutively active in some CLL patients (Fig. 4B). The gene discussed is LYN; the disease is B-cell non-Hodgkin lymphoma.